Coagulation-Related Variants Emerge in a Small IVF Failure Cohort
A case-control study from Uzbekistan places F3 and F7 polymorphisms at the center of a familiar reproductive question: why do some women experience repeated IVF failure despite embryo transfer and routine preparation? Investigators compared 90 women with one to five unsuccessful IVF attempts with 25 fertile controls and found substantially different allele frequencies for both genes. The F3 T allele appeared more often in the IVF failure group than in controls, while the F7 A allele showed an even larger separation between groups. The study also examined coagulation measurements and uterine Doppler indices, tying genetic findings to the local vascular environment in the uterus rather than treating the variants as isolated laboratory curiosities.
The signal is biologically plausible. Tissue factor, encoded by F3, sits near the start of the extrinsic coagulation cascade, and factor VII participates in the same pathway. If either pathway is shifted toward a prothrombotic state, the endometrial and placental interface may be less forgiving during implantation, when microvascular remodeling and stable perfusion are essential. In reproductive medicine, even small disturbances in coagulation biology can matter if they alter the endometrial bed at the exact moment an embryo needs attachment and early support.
Allele Differences Were Large, but the Cohort Was Small
The unadjusted genetic associations were striking. The F3 T allele was present in 32.8% of cases versus 12.0% of controls, yielding an odds ratio of 3.58 with a 95% confidence interval of 1.44 to 8.87 and a p value of 0.00389. The F7 A allele showed an even more dramatic separation, occurring in 58.3% of cases versus 8.0% of controls, with an odds ratio of 16.10 and a 95% confidence interval of 5.56 to 46.65; the p value was 2.87 × 10⁻¹⁰.
Those numbers suggest association, not proof of causation. The sample was modest, the analysis was unadjusted, and the case-control design cannot determine whether the variants directly contributed to implantation failure or simply tracked with another reproductive or vascular factor. Still, the size of the difference invites serious attention, especially because both genes map onto a pathway that could plausibly shape uterine microcirculation and local thrombin generation. In a field where many failure mechanisms remain invisible to standard infertility workups, a coagulation-linked genotype deserves a place in the conversation.
Uterine Perfusion and Hemostatic Measures Added a Physiologic Layer
The study did not stop at genotyping. Investigators also measured coagulation parameters and Doppler indices of uterine and endometrial perfusion, attempting to connect inherited variation with a real-world reproductive phenotype. That approach matters because implantation failure is rarely a single-gene event; it is more often the result of mismatched embryo quality, endometrial receptivity, vascular support, and coagulation balance converging at the same moment. By examining perfusion, the investigators moved beyond a simple association study and toward a mechanistic framework in which a procoagulant tendency could interfere with blood flow in the endometrial bed.
The uterine circulation is a narrow bottleneck. If vascular resistance is altered or if coagulation activity rises in the peri-implantation window, the embryo may encounter a hostile interface before pregnancy can establish itself. Even subtle shifts in perfusion can have consequences when the biologic margin for error is small.
Preconception Preparation Was Associated With More Ongoing Pregnancies
A separate non-randomized comparison looked at ongoing pregnancy among women who received complete preconception preparation and those who received no or incomplete preparation. Ongoing pregnancy occurred in 20 of 44 women, or 45.5%, in the complete-preparation group, compared with 10 of 46 women, or 21.7%, in the group without full preparation. The odds ratio was 3.00 with a 95% confidence interval of 1.20 to 7.51, and the two-sided Fisher exact p value was 0.02492.
The difference is clinically attractive, but the study design prevents a clean treatment claim. Allocation was not randomized, and confounding could easily explain part or all of the separation. Women who completed preconception preparation may also have differed in baseline prognosis, adherence, access to care, or the intensity of their evaluation before embryo transfer. The result still has bedside relevance because it reinforces a long-standing reproductive medicine principle: optimization before transfer may matter as much as the transfer itself, particularly when coagulation and vascular biology are under suspicion.
What the Findings Can and Cannot Support
The most defensible interpretation is narrow. F3 and F7 polymorphisms showed unadjusted associations with prior IVF failure in this Uzbek cohort, and complete preconception preparation tracked with a higher proportion of ongoing pregnancies. Neither observation is sufficient to change practice on its own. The genetic results need replication in larger, prospectively designed studies with adjustment for confounders and clearer definition of the clinical phenotype. The pregnancy comparison also requires randomized or carefully controlled prospective validation before anyone treats it as evidence of efficacy.
Even so, the study points toward a practical hypothesis: inherited coagulation variation may influence implantation through uterine perfusion and hemostatic balance. If future studies confirm the relationship, reproductive workups may need to look more closely at thrombosis-related pathways in women with repeated IVF failure, especially when standard explanations have already been exhausted. For now, the data support investigation, not routine clinical adoption.
The unresolved issue is not whether implantation biology is complex; it clearly is. The real question is whether these specific coagulation variants identify a subgroup in whom targeted preconception optimization can improve pregnancy outcomes, and that will require prospective validation before the field can act with confidence.